Venous thromboembolisms (VTE), or blood clots in the veins, affect as many as 900,000 Americans in the U.S. each year, about 50 percent of them are healthcare-associated, and as many as 70 percent of ...

Venous thromboembolism (VTE) represents both a significant health threat for at-risk patients and a financial burden. Meanwhile, provider organizations that fail to focus on and prevent VTE from ...

In patients with active cancer who have been hospitalized for a venous thromboembolism (VTE) event, rivaroxaban (Xarelto; Bayer/Janssen) is as effective as apixaban (Eliquis; Bristol-Myers Squibb) in ...

At the end of 6 months, the rate of VTE recurrence was 4% among rivaroxaban patients vs 11% in the dalteparin arm (hazard ratio [HR] 0.43, 95% CI: 0.19 to 0.99). Currently, international guidelines ...

Incidence of venous thromboembolism remains 'substantial' despite expert guidelines and newer risk prediction scores ...

The majority of fatal cases of pulmonary embolism in hospitalized patients occur in acutely ill, medically treated patients. Current guidelines, based on a large number of prospective, randomized, ...

The Health Research and Educational Trust, an affiliate of the American Hospital Association, offers a free venous thromboembolism prevention guide. The guide was developed by Cynosure Health in ...

WASHINGTON, DC—In patients at risk for recurrent venous thromboembolism (VTE), rivaroxaban is a better choice for continued therapy than aspirin, with no increased risk of bleeding, according to ...

In the Prevention of VTE in Acutely ill Patients, Rivaroxaban Compares Favorably with Enoxaparin but Does Not Show a Consistent Net Clinical Benefit MAGELLAN study meets primary efficacy endpoints of ...

DALLAS, TX — Daily aspirin can cut the adjusted recurrence risk by more than a third over three to four years after acute therapy for a first "unprovoked" venous thromboembolism (VTE), suggests a ...

Aspirin is as effective as dalteparin for venous thromboembolism (VTE) prevention after total hip arthroplasty (THA), according to a multicenter randomized, controlled trial of 778 patients. David R.

Please provide your email address to receive an email when new articles are posted on . The literature suggests that measures should be carried out to prevent venous thromboembolism in patients ...